URMC / Labs / Richardson Lab / Publications

Publications

1. Bender AM
2. Laageide L
3. Kaur J
4. Babkowski N
5. Richardson CT
Ruxolitinib cream for discoid lupus erythematosus: an open-label pilot study of ten subjects.; Journal of the American Academy of Dermatology. 2024 Nov 26.
1. Rahman SM
2. Bowden A
3. Green CB
4. Pentland AP
5. Richardson CT
6. DeBenedetto A
7. Plovanich M
8. Wolf JR
Identifying Care Gaps and Referral Patterns in Acute Dermatology at Urgent Care Centers.; Research square. 2024 Aug 14.
1. Guy DR
2. Mizes A
3. Richardson CT
Rapid response of omalizumab-resistant chronic urticaria to acalabrutinib.; JAAD case reports; Vol 47, pp. 47-49. 2024 Mar 15.
1. Kowalski EH
2. Kenney HM
3. Richardson CT
Wong-type dermatomyositis with interstitial lung disease and anti-SRP and -PM/Scl antibodies treated with intravenous immunoglobulin.; JAAD case reports; Vol 41, pp. 26-29. 2023 Sep 09.
1. Narayan N
2. Richardson CT
Serologic differences between dermatomyositis and antisynthetase syndrome using a commercially available autoantibody panel: a retrospective cohort study.; Journal of the American Academy of Dermatology. 2023 Jun 28.
1. Kowalski EH
2. Stolarczyk A
3. Richardson CT
Successful treatment of severe chronic cutaneous lupus with anifrolumab: A series of 6 cases.; JAAD case reports; Vol 37, pp. 21-29. 2023 May 04.
1. Shah S
2. Esaa FS
3. Baughman L
4. Gadarowski MB
5. Richardson CT
Differential effect of the 2019 EULAR/ACR classification criteria for systemic lupus on different cutaneous lupus subtypes.; Journal of the American Academy of Dermatology. 2023 Feb 03.
1. Yon J
2. Curran T
3. Richardson CT
Lack of cutaneous B cells differentiates lupus-like skin disease in MRL/lpr mice from human discoid lupus.; The Journal of investigative dermatology. 2023 Jan 13.
1. Narayan N
2. Richardson CT
Multiple myositis-specific autoantibodies in dermatomyositis: 2 cases and review of the literature.; JAAD case reports; Vol 25, pp. 72-74. 2022 Jun 03.
1. Lerman I
2. Bawany F
3. Whitt W
4. Esaa F
5. Yon J
6. Babkowski N
7. Rapp MB
8. Scott GA
9. Anolik JH
10. Richardson CT
Prominent B cell signature differentiates discoid from subacute cutaneous lupus erythematosus.; The Journal of investigative dermatology. 2022 May 17.
1. Kaur J
2. Zambito J
3. Richardson CT
Methotrexate injection site reactions: Case report and literature review.; JAAD case reports; Vol 23. 2022 May.
1. Lee G
2. Scott GA
3. Munsiff SS
4. Richardson CT
Locally recurrent primary cutaneous coccidioidomycosis.; JAAD case reports; Vol 16. 2021 Oct.
1. Lerman I
2. Mitchell DC
3. Richardson CT
Human cutaneous B cells: what do we really know?; Annals of translational medicine; Vol 9(5). 2021 Mar.
1. Pukhalskaya T
2. Stiegler J
3. Scott G
4. Richardson CT
5. Smoller B
Degos Disease (Malignant Atrophic Papulosis) With Granular IgM on Direct Immunofluorescence.; Cureus; Vol 13(1). 2021 Jan 13.
1. Dean O
2. Cusick EH
3. Grover R
4. Mercurio MG
5. Richardson CT
Congenital absence of the skin secondary to the self-improving subtype of dystrophic epidermolysis bullosa with recurrent lesions throughout early childhood.; JAAD case reports; Vol 7. 2021 Jan.
1. Bawany F
2. Tbakhi B
3. Mendler JH
4. Richardson CT
5. Bennett JM
6. Aljitawi OS
Remission of anti-TIF1γ dermatomyositis after allogeneic hematopoietic stem cell transplant for myelodysplastic syndrome.; Blood advances; Vol 4(22). 2020 Nov 24.
1. Whitt W
2. Stiegler JD
3. Richardson CT
Autoimmune progesterone dermatitis mimicking facial erythromelalgia successfully treated with hysterectomy and bilateral salpingo-oophorectomy.; JAAD case reports; Vol 6(10). 2020 Oct.
1. Moran MC
2. Beck LA
3. Richardson CT
A Spectrum of Skin Disease: How Staphylococcus aureus Colonization, Barrier Dysfunction, and Cytokines Shape the Skin.; The Journal of investigative dermatology; Vol 140(5). 2020 May.
1. Mitchell DC
2. Agnihothri R
3. Scott GA
4. Korman B
5. Richardson CT
A case of concurrent systemic sclerosis and scleredema.; JAAD case reports; Vol 5(11). 2019 Nov.
1. Lerman I
2. Agnihothri R
3. Scott GA
4. Richardson CT
An atypical clinical presentation of alopecia in 2 patients with systemic lupus erythematosus.; JAAD case reports; Vol 5(11). 2019 Nov.
1. Lerman I
2. Richardson CT
Anti-TIF1gamma Antibody-Positive Dermatomyositis Associated with Myelodysplastic Syndrome: Response to Treatment.; Cureus; Vol 11(9). 2019 Sep 26.
1. Dziwis J
2. Agnihothri R
3. Lieberman A
4. Richardson CT
A unique case of dermatomyositis associated with anti-TIF1γ antibody and chondrosarcoma.; JAAD case reports; Vol 5(9). 2019 Sep.
1. Richardson CT
2. Slack MA
3. Dhillon G
4. Marcus CZ
5. Barnard J
6. Palanichamy A
7. Sanz I
8. Looney RJ
9. Anolik JH
Failure of B Cell Tolerance in CVID.; Frontiers in immunology; Vol 10. 2019.
1. Richardson CT
2. Hayden MS
3. Gilmore ES
4. Poligone B
Evaluation of the Relationship between Alopecia Areata and Viral Antigen Exposure.; American journal of clinical dermatology; Vol 19(1). 2018 Feb.
1. Rapp M
2. Pentland A
3. Richardson C
Successful Treatment of Pemphigus Vulgaris With Ofatumumab; Journal of drugs in dermatology : JDD; Vol 17(12). 2018 Jan 01.
1. Alexander-Savino CV
2. Hayden MS
3. Richardson C
4. Zhao J
5. Poligone B
Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells.; Oncotarget; Vol 7(46). 2016 Nov 15.
1. Jenks SA
2. Palmer EM
3. Marin EY
4. Hartson L
5. Chida AS
6. Richardson C
7. Sanz I
9G4+ autoantibodies are an important source of apoptotic cell reactivity associated with high levels of disease activity in systemic lupus erythematosus.; Arthritis and rheumatism; Vol 65(12). 2013 Dec.
1. Richardson C
2. Chida AS
3. Adlowitz D
4. Silver L
5. Fox E
6. Jenks SA
7. Palmer E
8. Wang Y
9. Heimburg-Molinaro J
10. Li QZ
11. Mohan C
12. Cummings R
13. Tipton C
14. Sanz I
Molecular basis of 9G4 B cell autoreactivity in human systemic lupus erythematosus.; Journal of immunology (Baltimore, Md. : 1950); Vol 191(10). 2013 Nov 15.